ARTICLES BY RONALD A. RADER

• COVID-19’s Impact On Bioprocessing: Insights From Industry Leaders

  We interviewed 26 biopharma senior executives regarding how they are handling the crisis and its long-term impact on their operations. We found the pandemic has begun to catalyze and accelerate a number of significant changes, including many preexisting trends.

• Biosimilar Pipeline Experiencing 12% Annual Growth: A Progress Update

  This article compares aspects of the biosimilar development pipeline and related market evolution since 2013, including what has and hasn’t changed.

• Biosimilars Pipeline Shows Remarkable, Sustained Growth

  The biosimilars pipeline is progressing rapidly and continues to grow, with more products and more organizations involved. This article reviews the current biosimilars development pipeline and progress. 

• Top Trends In The Biopharmaceutical Industry And Bioprocessing For 2019

  This article presents trends and findings from a survey and study of 222 responsible individuals at biopharmaceutical manufacturers and CMOs in 22 countries, as well as over 130 direct suppliers of materials, services, and equipment to this industry.

• Biosimilars Pipeline Analysis: Many Products, More Competition Coming

  Our discussion of biosimilars in this article will center on developed-market GMP biosimilars. In the European market alone, biosimilars already are a multibillion-dollar business, and one that is rapidly growing.